According to new study at Rutgers University, micro tumors could be spotted by latest technology
Cancer screening has just gained a new ally with the latest research assessing the most efficient way of spotting micro metastases in real time.
Scientists from Rutgers University in New Brunswick, led by Prof. Prabhas V. Moghe, have performed tests using light-emitting nanoparticles able to detect cancerous cells in very incipient stages.
In order to reach their conclusions, the researchers have used mouse models of human breast cancer. As a result, the nanoprobes injected into the bloodstream were able to send a reliable image of the micrometastases.
As the method works faster than an MRI scan, with the help of nanotechnology doctors could be more efficient in diagnosing cancer, while this way patients will benefit higher survival rates.
“Cancer cells can lodge in different niches in the body, and the probe follows the spreading cells wherever they go. You can treat the tumors intelligently because now you know the address of the cancer,” comments co-author Vidya Ganapathy.
According to the study, the nanoparticles can successfully detect at least 100 different types of cancer.
This cutting-edge technology will probably be available for cancer screening and immunotherapy efficiency testing within the next 5 years.
The new research have been published in the journal Nature Biomedical Engineering.